Cme Group Stock Current Asset
| MX4A Stock | EUR 223.10 5.65 2.47% |
CME Group fundamentals help investors to digest information that contributes to CME's financial success or failures. It also enables traders to predict the movement of CME Stock. The fundamental analysis module provides a way to measure CME's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CME stock.
CME |
CME Group Company Current Asset Analysis
CME's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, CME Group has a Current Asset of 0.0. This is 100.0% lower than that of the Financial Services sector and 100.0% lower than that of the Financial Exchanges industry. The current asset for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
CME Fundamentals
| Return On Equity | 0.0992 | |||
| Return On Asset | 0.0101 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.60 % | |||
| Current Valuation | 60.85 B | |||
| Shares Outstanding | 359.72 M | |||
| Shares Owned By Insiders | 0.45 % | |||
| Shares Owned By Institutions | 88.31 % | |||
| Price To Earning | 35.53 X | |||
| Price To Book | 2.16 X | |||
| Price To Sales | 12.30 X | |||
| Revenue | 5.02 B | |||
| Gross Profit | 5.01 B | |||
| EBITDA | 4.02 B | |||
| Net Income | 2.69 B | |||
| Cash And Equivalents | 1.02 B | |||
| Cash Per Share | 2.86 X | |||
| Total Debt | 3.42 B | |||
| Debt To Equity | 15.30 % | |||
| Current Ratio | 1.05 X | |||
| Book Value Per Share | 74.89 X | |||
| Cash Flow From Operations | 3.06 B | |||
| Earnings Per Share | 6.98 X | |||
| Price To Earnings To Growth | 4.38 X | |||
| Target Price | 221.47 | |||
| Number Of Employees | 3.46 K | |||
| Beta | 0.41 | |||
| Market Capitalization | 62.87 B | |||
| Total Asset | 174.18 B | |||
| Z Score | 10.8 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.84 % | |||
| Net Asset | 174.18 B | |||
| Last Dividend Paid | 4.0 |
About CME Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CME Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CME using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CME Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CME Stock
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.